June 16 (Reuters) - U.S. drugmaker Eli Lilly LLY.N said on Monday it will offer the higher dose versions of its popular weight-loss drug Zepbound on its website LillyDirect.
The company said 12.5 milligrams and 15 mg doses of the drug will be available for $499 per month on the website with shipments to patients beginning in early August.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shailesh Kuber)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.